Publications Database

Erickson C. A. , Mullett J. E. , McDougle C. J. (2009)

Open-label memantine in fragile X syndrome.

Journal of Autism and Developmental Disorders

39(12), pp. 1629-1635.

Read Abstract (New Window)

Erickson C. A. et al. (2014)

STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study.

Journal of Autism and Developmental Disorders

44(4), pp. 958-964.

Read Abstract (New Window)

Fitzpatrick S. E. et al. (2016)

Aggression in autism spectrum disorder: presentation and treatment options.

Neuropsychiatric Disease and Treatment

2016(12), pp. 1525-1538

Read Abstract (New Window) Read Full (New Window)

Kowalski J. et al. (2011)

Paliperidone palmitate in a child with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

October, 21(5), pp. 491-493

McDougle C. J. et al. (2008)

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

Journal of Clinical Psychiatry

69 pp.15-20

Read Abstract (New Window)

McGuire K. et al. (2015)

Psychiatric hospitalization of children with autism or intellectual disability: Consensus statements on best practices.

Journal of the American Academy of Child and Adolescent Psychiatry

December, 54(12), pp. 969-971.

Read Abstract (New Window)

Minshawi N. F. et al. (2016)

A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders.

Molecular Autism

7(2),

Read Full (New Window)

Nikolov R. N. et al. (2009)

Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

39(3), pp. 405-413

Read Abstract (New Window)

Orsagh-Yentis D. K. et al. (2011)

Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Posey D. J. et al. (2008)

Antipsychotics in the treatment of autism.

Journal of Clinical Investigation

118(1), pp. 6-14

Read Abstract (New Window) Read Full (New Window)

Posey D. J. , Erickson C. A. , McDougle C. J. (2008)

Developing drugs for core social and communication impairment in autism.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 787-801

Read Abstract (New Window) Read Full (New Window)

Posey D. J. et al. (2006)

The use of selective serotonin reuptake inhibitors in autism and related disorders.

Journal of Child and Adolescent Psychopharmacology

16(1), pp. 181-186

Read Abstract (New Window)

Stigler K. A. et al. (2009)

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

Journal of Child and Adolescent Psychopharmacology

19(3), pp. 265-274

Read Abstract (New Window) Read Full (New Window)

Stigler K. A. et al. (2010)

Paliperidone for irritability in autistic disorder.

Journal of Child and Adolescent Psychopharmacology

pp. 75-78

Read Extract (New Window)

Wink L. K. et al.

A randomized placebo-controlled cross-over pilot study of riluzole for drug-refractory irritability in autism spectrum disorder.

Journal of Autism and Developmental Disorders

Read Abstract (New Window)

Wink L. K. et al. (2016)

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.

Molecular Autism

7(26),

Read Full (New Window)

Wink L. K. et al. (2017)

Brief report: Metformin for antipsychotic-induced weight gain in youth with autism spectrum disorder.

Journal of Autism and Developmental Disorders

July, 47(7), pp. 2290–2294.

Read Abstract (New Window)

Wink L. K. et al. (2017)

d-Cycloserine enhances durability of social skills training in autism spectrum disorder.

Molecular Autism

Read Abstract (New Window) Read Full (New Window)

Wink L. K. et al. (2010)

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Expert Opinion on Emerging Drugs

September, 15(3), pp. 481-494

Read Abstract (New Window)

Wink L. K. , Erickson C. A. , McDougle C. J. (2010)

Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders.

Current Treatment Options in Neurology

12(6), pp. 529-538.

Read Abstract (New Window)